Global Pneumococcal Vaccine Market Size, Industry Trends, Share and Forecast 2020-2026


Posted July 13, 2020 by mansi3210

Global Pneumococcal Vaccine Market Size, Share & Trends Analysis Report, By Vaccine Type , Pneumococcal Polysaccharide Vaccine , , By Distribution Channel By Type , By Age Group and Forecast, 2020-2026

 
The pneumococcal vaccine market is expected to show considerable growth at a CAGR of around 4.0% during the forecast period 2020-2026. Major factors for the growth of the market include high spending to curb pneumonia among children in the developed economies. Moreover, increasing healthcare infrastructure in the emerging economies, rising per capita healthcare expenditure, and growing awareness toward vaccination are also augmenting the market growth. In addition, innovations in the pneumonia vaccines are also providing significant opportunities to the market.

Request a Free Sample of our Global Pneumococcal Vaccine Market: https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market

As per a report by John Hopkins, around 5.7 million children were died before attaining the age of 5 years in 2016 out of which nearly 25% were due to pneumonia or diarrhea. 15 countries, mainly in Asia and Africa have the most burden of pneumonia. As in 2018, 55% of the global under 5-year age population resides in these countries however they represent 70% of the global under-5 pneumonia and diarrhea deaths. The countries include China, India, Indonesia, Nigeria, Pakistan, the Democratic Republic of the Congo, Ethiopia, Chad, Angola, Somalia, Tanzania, Niger, Bangladesh, Uganda, and Côte d'Ivoire. Growth in the private healthcare expenditure in the emerging economies such as India, China, and Indonesia, and increasing investment by government and international organizations will provide a significant opportunity to the market.

A full Report of Global Pneumococcal Vaccine Market is Available at: https://www.omrglobal.com/industry-reports/pneumococcal-vaccine-market

GAVI (the Vaccine Alliance), is significantly working toward the children vaccination in the emerging economies. In June 2009, countries including Italy, UK, Canada, Russia, Norway, and Bill & Melinda Gates Foundation have contributed $1.5 billion for Gavi’s vaccination program, Advance Market Commitment (AMC). Due to this, in Gavi supported countries pneumonia vaccination coverage has increased to 48% in 2018 (higher than the global average of 47%), compared to 37% in 2015. By the end of 2018, more than 183 million children have been vaccinated against pneumococcal disease through Gavi. Moreover, two vaccine manufacturers have pledged to provide 1.65 billion doses through 2027. The prices of GAVI’s vaccine dose are also decreasing continuously. During the start of the AMC, the price of the vaccine for the Gavi was $3.5 per dose. After a new agreement with the Serum Institute of India in June 2020, the vaccine will price $2 per dose. Under the agreement, the company will provide 10 million PCV doses every year to Gavi supported countries for the next ten years.

Global Pneumococcal Vaccine Market Segmentation

By Vaccine Type

• Pneumococcal Conjugate Vaccine (PCV13)
• Pneumococcal Polysaccharide Vaccine (PPSV23)
• Other

By Distribution Channel

• Public (Government & Non-Government)
• Private

By Type

• Branded
• Generic
By Age Group

• Children
• Adult

Regional Analysis

• North America
• United States
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Company Profiles

• Astellas Pharma Inc.
• China National Biotec Group Company Ltd.
• CSL Ltd.
• GlaxoSmithKline PLC
• Merck & Co., Inc.
• Novavax, Inc.
• Pfizer Inc.
• Walvax Biotechnology Co., Ltd.
• SK Bioscience
• Sanofi SA
• Serum Institute of India Pvt. Ltd.
• PnuVax Incorporated

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pneumococcal-vaccine-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mansi Jain
Phone 07803040404
Business Address Orion Market Research Pvt Ltd
305-308, Commerce House,
Country India
Categories Business , Health , Medical
Tags market analysis , market forecast , market research , pharmaceuticals
Last Updated July 13, 2020